
🧠Containing my own work on apparent penetrance TSC1/TSC2 in population biobanks published just in time for #ESHG2026 springernature.eu.qualtrics.…...

Prof Emma Baple & team @ExeterMed defining the genomic & molecular basis of rare diseases. futurelearn.com/courses/comm…

🧠Containing my own work on apparent penetrance TSC1/TSC2 in population biobanks published just in time for #ESHG2026 springernature.eu.qualtrics.…...

🧬 Leigh Jackson (Exeter) presents multiple papers (see EJHG Special Issue ☝️ ) #ESHG2026 Penetrance of TSC, PCD, OI & RB1 across ~900,000 adults Careful variant & phenotype curation matters In clinically unselected populations, disease risk ⬇️ vs traditional estimates.

Caroline Wright (Exeter) sharing fundamental knowledge What does the "average" human genome look like?" >900k 🧬 #UKB / #AllofUs / Genome: 1️⃣ ~4.4–5.5 million variants 2️⃣ 2–3 ClinVar P/LP (mostly AR) 3️⃣ ~62–70 de novo variants 4️⃣ ~1 in 5 people in top 1% of PRS for ≥1 disease

For the 2nd year running I am representing the sleepy Devon town of Ivybridge 🙄 I also claim affiliations with the *Exeter Genomics powerhouse* - 38 presenters at #ESHG2026! **We are recruiting** Clinical geneticists - academic and non-academics Would love to chat 😊

Between 2024-2025 the Unique team were involved in 13 academic papers, covering topics like benefits, harms and costs of genomic newborn screening, promoting timely and equitable access to rare disease genomic testing and more! We're always looking for ways to raise awareness!

We are looking to bring new talent and clinical academic leaders to Exeter and the South West. Freedom to explore your research ideas in a wonderful setting, do get in touch for an informal discussion @UniofExeter
Clinical Academic opportunities in Genomic Medicine (Senior Lecturer & Professor). Joint University of Exeter / Royal Devon posts, embedded in the NIHR Exeter BRC and the new SW Clinical Genetics Service. 📅 Apply by 22 March 2026 🔎 jobs.exeter.ac.uk | Genomic Medicine

Thank you again for attending the NHS Genomic Healthcare Summit 2025🙏 📢 We'd love to hear your feedback or suggestions as we look ahead for planning next year. Leave a comment below or DM us directly to share your thoughts! 💬 #NHSGenomics2025 #NHSGHS

Haplotype studies and the use of a nearby tagging variant confirm a founder origin for an intragenic CYP11B1 inversion - go.shr.lc/4aVSv8j

happy to have contributed with our group to this very fascinating paper on a new disease mechanism for a neurodegenerative disorder #genetics @AJHGNews #raredisease
📣New from @RDExeter 📄Palindrome-mediated 16p13.3 triplications cause a recognizable neurodegenerative disorder with ataxia cell.com/ajhg/fulltext/S0002…

⌛There is still time to join the Genomics Clinical Reference Group (CRG) patient and public voice (PPV). 3 partners are needed to help inform and shape the future of the NHS GMS. 📅Closing on Friday 12 December 2025. DM or email england.genomics@nhs.net to find out more.

Amicia Phillips challenging traditional definitions of 'actionability' in the context of genomic #newbornscreening #ICoNS25

Thanks @UKHSPGroup for having me at your regional meeting on Saturday! It was great to talk about the HSP research at @ExeterMed and hear lots of interesting thoughts / questions.

More than meets the eye. Non-canonical #FBN1 splice variants may account for ~3% of families with undiagnosed #FTAAD. bit.ly/3IhIN48 #Marfansyndrome @alistairp2011 @SureshSomarathi @LaughingGenome @smbanka @JamesFasham @ProfDBaralle @RDExeter @GenomicsEngland

This will improve diagnosis & treatment for thousands of patients 🌍 👏🏼 Amazing @adam_jackson89 👍🏼 @NishiThake91821 @DrABlakes 🙏🏼all collaborators @mft_iMRare @MFT_Research @ManchesterBRC @EGS_UoM @FBMH_UoM @EpiGenRare @RDRUKHub @Unique_charity nature.com/articles/s41588-0… 🧬
We are excited to share our new paper out today in Nature Genetics which explores de novo mutations in DNA secondary structure and identifies two novel #diseasegenes nature.com/articles/s41588-0…

@ExeterGenomes are celebrating!! The team in Exeter have been delivering diagnoses for children with rare genetic diseases since 2013. Initially as exomes, now thriving as a national rapid genome sequencing service (R14). We've just passed our 9000th family 😮🎉🥳 @SWGLH

As we approach the year's end, I want to say a heartfelt thanks to the NHS healthcare science community and I hope you can take a break over the festive period. Please know that your contributions are deeply valued and we look forward to 2025 being another groundbreaking year.